Get started
Author

Oliver Charles Cohen

Observed names: Cohen, Oliver, Cohen, Oliver Charles, O Cohen, O. Cohen, Oliver C Cohen, Oliver C. Cohen, Oliver Cohen, Oliver C. Cohen
ORCID: 0000-0003-4095-0505
Observed ORCIDs: 0000-0003-4095-0505, 0000-0002-1950-3172
OpenAlex ID: A5037780654
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324
A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib
2019 · Richa Manwani, Oliver Cohen, et al. · Blood · 194
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
2020 · David Adams, Michael Polydefkis, et al. · The Lancet Neurology · 159
Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis
2021 · Oliver C Cohen, Andreia Ismael, et al. · European Heart Journal · 113
Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis
2022 · Eli Muchtar, Angela Dispenzieri, et al. · Journal of Clinical Oncology · 94
PDF
Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma
2020 · Nouf Alrasheed, Lydia Lee, et al. · Clinical Cancer Research · 74
Characteristics and natural history of early-stage cardiac transthyretin amyloidosis
2022 · Steven Law, Melanie Bezard, et al. · European Heart Journal · 66
PDF
Disease Progression in Cardiac Transthyretin Amyloidosis is Indicated by Serial Calculation of National Amyloidosis Centre Transthyretin Amyloidosis Stage
2020 · Steven Law, Aviva Petrie, et al. · ESC Heart Failure · 46
PDF
Cardiac Magnetic Resonance–Derived Extracellular Volume Mapping for the Quantification of Hepatic and Splenic Amyloid
2021 · Liza Chacko, Michele Boldrini, et al. · Circulation Cardiovascular Imaging · 45
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy
2025 · David Adams, Jonas Wixner, et al. · JAMA Neurology · 40
PDF
Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group
2022 · Andrea Havasi, Cihan Heybeli, et al. · Blood Cancer Journal · 40
PDF
Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis
2024 · Joshua Bomsztyk, Sriram Ravichandran, et al. · Blood · 38
PDF
Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light‐chain amyloidosis
2020 · Oliver C. Cohen, Faye Sharpley, et al. · British Journal of Haematology · 37
PDF
Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL Amyloidosis
2024 · Aldostefano Porcari, Ambra Masi, et al. · JAMA Cardiology · 35
Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib
2021 · Sriram Ravichandran, Oliver C. Cohen, et al. · Blood Cancer Journal · 34
PDF
Renal transplant outcomes in amyloidosis
2020 · Steven Law, Oliver Cohen, et al. · Nephrology Dialysis Transplantation · 34
PDF
Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis
2024 · Eli Muchtar, Brendan Wisniowski, et al. · JAMA Oncology · 31
PDF
Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy
2021 · Steven Law, Aviva Petrie, et al. · Heart · 28
PDF
Systemic amyloidosis: moving into the spotlight
2020 · Oliver C. Cohen, Ashutosh D. Wechalekar · Leukemia · 25
PDF
The experience of hereditary apolipoprotein A-I amyloidosis at the UK National Amyloidosis Centre
2022 · Oliver C. Cohen, Iona J. Blakeney, et al. · Amyloid · 23
The value of screening biopsies in light‐chain (AL) and transthyretin (ATTR) amyloidosis
2020 · Oliver C. Cohen, Faye Sharpley, et al. · European Journal Of Haematology · 23
PDF
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
2023 · Laura Obici, Senda Ajroud-Driss, et al. · Neurology and Therapy · 21
PDF
Prognostic importance of the 6 min walk test in light chain (AL) amyloidosis
2022 · Oliver C Cohen, Ananth Sathyanath, et al. · Heart · 17
PDF
Lymph node core biopsies reliably permit diagnosis of lymphoproliferative diseases. Real‐World Experience from 554 sequential core biopsies from a single centre
2020 · Oliver C. Cohen, Maximillian H. Brodermann, et al. · European Journal Of Haematology · 17
PDF
Works count: 80
Citation count: 2,079
H-index: 22
I10-index: 30
Year
Topic
Type